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ABSTRACT
In all biological systems, RNAs are associated with
RNA-binding proteins (RBPs), forming complexes
that control gene regulatory mechanisms, from RNA
synthesis to decay. In mammalian mitochondria,
post-transcriptional regulation of gene expression is
conducted by mitochondrial RBPs (mt-RBPs) at var-
ious stages of mt-RNA metabolism, including poly-
cistronic transcript production, its processing into
individual transcripts, mt-RNA modifications, stabil-
ity, translation and degradation. To date, only a hand-
ful of mt-RBPs have been characterized. Here, we
describe a putative human mitochondrial protein,
C6orf203, that contains an S4-like domain––an evolu-
tionarily conserved RNA-binding domain previously
identified in proteins involved in translation. Our data
show C6orf203 to bind highly structured RNA in vitro
and associate with the mitoribosomal large subunit
in HEK293T cells. Knockout of C6orf203 leads to
a decrease in mitochondrial translation and conse-
quent OXPHOS deficiency, without affecting mito-
chondrial RNA levels. Although mitoribosome stabil-
ity is not affected in C6orf203-depleted cells, mitori-
bosome profiling analysis revealed a global disrup-
tion of the association of mt-mRNAs with the mitori-
bosome, suggesting that C6orf203 may be required
for the proper maturation and functioning of the mi-
toribosome. We therefore propose C6orf203 to be a
novel RNA-binding protein involved in mitochondrial
translation, expanding the repertoire of factors en-
gaged in this process.
INTRODUCTION
Ribonucleic acid (RNA)-binding proteins (RBPs) play a
central role in mediating the regulation of gene expression
in all organisms. They associate with nascent transcripts
and subsequently regulate all steps of mRNA life from
processing, localization, translation to turnover. Multiple
RBPs also associate with noncodingRNA (ncRNA), affect-
ing their structures and catalytic activities. The number of
novel RBPs is rapidly growing due to the implementation
of highly sensitive identification tools (1). In recent years,
RNA interactome capture and its modifications have iden-
tified over 1000 eukaryotic RBPs, many of which had no
prior RNA-related annotation (2,3). Importantly, defects in
many of these factors have been implicated in a broad spec-
trum of human pathologies, prominently neurological, sen-
sory, and muscular disorders and cancers (4–6). A deeper
insight into the role of RBPs in genetic disease requires the
in-depth characterization of their mechanism of action in
vivo and dynamic mapping of their target interactions.
In human mitochondria, post-transcriptional gene ex-
pression is orchestrated by numerous RBPs that are pro-
duced in the cytosol and imported into the organelle. The
mitochondrial genome (mtDNA) encodes 13 proteins, all
of which are essential components of the oxidative phos-
phorylation (OXPHOS) system. In addition tomt-mRNAs,
all RNA elements required for in organellar translation,
two ribosomal RNAs (mt-rRNAs: 12S and 16S) incorpo-
rated into themitochondrial ribosome (mitoribosome), and
a complete set of transfer RNAs (22 mt-tRNAs) are also
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encoded by mtDNA. From the moment the nascent poly-
cistronic transcripts are produced, mtRBPs are involved in
their processing and maturation: long polycistronic tran-
scripts undergo endonucleolytic processing by RNase P
and ELAC2 that releases individual transcripts. Most of
the mRNAs are polyadenylated and stabilized by interac-
tion with the LRPPRC–SLIRP complex, mt-rRNAs are
subjected to methylation and pseudouridylation, and mt-
tRNAs undergo several types of nucleotide modifications,
CCA addition and aminoacylation (7). Many of these pro-
cesses take place in mitochondrial RNA granules, dynamic
structures that also serve as hubs for early mitoribosome
assembly (8).
Human mitoribosomes are complex machineries consist-
ing of 82 protein and 3 RNA components (2 rRNAs and
mt-tRNAVal) (9,10). Their assembly proceeds in a highly
organized manner, requiring the action of numerous fac-
tors that help mt-rRNA folding, coordinate sequential ar-
rival of integral ribosomal proteins and allow association of
the mitoribosome with the mitochondrial inner membrane.
Several GTPases, RNA helicases and chaperone-like fac-
tors have been implicated in mitoribosome biogenesis, al-
though our understanding of this process is far from com-
plete (11,12). The high complexity of the human mitoribo-
some and numerous differences between the mitochondrial
and bacterial translation systems suggest the involvement
of as-yet-unknown mitochondria-specific factors, with no
bacterial descendants.
This missing information led us in search of putative mi-
tochondrial RBPs involved in mitochondrial gene expres-
sion and mitoribosome maturation. In silico analysis of the
proteins that contain RNA-binding domains, together with
our systematic SILAC-based mass spectrometry detection
of the components of mitochondrial translation machin-
ery (unpublished), directed our focus to C6orf203 (Chro-
mosome 6 open reading frame 203), a putative mitochon-
drial protein listed in the MitoCarta inventory of mam-
malian mitochondrial proteins (13). C6orf203 is predicted
to contain an S4-like domain, an RNA-binding domain
found in several translation-associated RBPs, including ri-
bosomal protein S4 (14). Here, we show that C6orf203
binds highly structured RNA in vitro and interacts with
the mitochondrial ribosomal large subunit (mt-LSU) in
human cells. Loss of C6orf203 leads to diminished mito-
chondrial translation and consequently, to respiratory in-
competence. We propose that C6orf203 is required for the
maturation/modulation of activity of the mitoribosomal
large subunit and, therefore, efficient mitochondrial trans-
lation.
MATERIALS AND METHODS
For a comprehensive list of antibodies and oligonucleotides
used in this study, please refer to accompanying Supplemen-
tary Tables S1–S5.
Cell maintenance and generation of stable cell lines
To generate stable mammalian cell lines that possess a
doxycycline-inducible expression of the C-terminal FLAG
tagged C6orf203 (C6orf203::FLAG) in a dose-dependent
manner, Flp-In T-Rex human embryonic kidney 293T
(HEK293T, Invitrogen) cell line was used. HEK293T
cells were cultured in DMEM (Dulbecco’s modified Ea-
gle medium) supplemented with 10% (v/v) tetracycline-
free fetal bovine serum (FBS), 2 mM GlutaMax (Gibco),
1× Penicillin/Streptomycin (Gibco), 50 g/ml uridine,
100 g/ml Zeocin (Invitrogen) and 10 g/ml blasticidin
(Gibco) at 37◦C under 5% CO2 humidified atmosphere.
Twenty-four hours prior to transfection, cells were split
to 100-mm plates in culture medium lacking selective
antibiotics and grown to 80–90% confluence. Transfec-
tion of pcDNA5/FRT/TO-C6orf203::FLAG construct and
pOG44 was performed using Lipofectamine 3000 (Invitro-
gen) according to the manufacturer’s instructions. Forty-
eight hours after transfection, the selective antibiotics
hygromycin (100 g/ml, Invitrogen) and blasticidin (10
g/ml) were added, and selective medium was replaced ev-
ery 3–4 days.
For immunocytochemistry, human 143B osteosar-
coma (HOS) cells were cultured in DMEM supple-
mented with 10% (v/v) FBS, 2 mM GlutaMax and
1× Penicillin/Streptomycin at 37◦C under 5% CO2
humidified atmosphere. Cells were transfected with
pcDNA5/FRT/TO-C6orf203::FLAG using Lipofectamine
3000 according to manufacturer’s instructions.
The generation of the HEK293T knockout cell line for
C6orf203 was performed using CRISPR/Cas9 system as
described in (15). Briefly, guide RNAs (gRNAs) designed to
generate an out-of-frame deletion in exon 1were cloned into
pSpCas9(BB)-2A-Puro (pX459) V2.0 vector. C6orf203 tar-
geting pX459 vectors were transfected to cells using Lipo-
fectamine 3000 according to the manufacturer’s instruc-
tions. After 48 h of puromycin (1.5 g/ml) selection, cells
were serially diluted to plate single cells in each well of a
96-well plate. Resultant clones were screened by PCR and
Western blotting. Loss of C6orf203 in selected clones was
confirmed by Sanger sequencing.
For growth measurements, 50 000 cells were seeded
in six-well plates in glucose-free DMEM containing 10
mM Galactose, 10% (v/v) FBS, 2 mM GlutaMax, 1×
Penicillin/Streptomycin and 1× Sodium Pyruvate (Gibco).
Cell number was counted every 48 h up to 6 days with
EVE™ Automated Cell Counter (NanoEnTek) as per the
manufacturer’s instructions.
Immunodetection of proteins
For immunoblot analysis, cultured cells or isolated mito-
chondria were lysed and the protein concentration was
determined by Pierce™ BCA Protein Assay Kit (Thermo
Fisher Scientific). Equal amounts of proteins correspond-
ing to total cell lysates or protein fractions were subjected to
SDS-PAGE, wet transferred to PVDFmembranes, blocked
in 5% non-fat milk (Semper) in PBS for 1 h and incubated
with specific primary antibodies in 5% non-fat milk in PBS
for 1 h or overnight. The blots were further incubated with
HRP-conjugated secondary antibodies in 5% non-fat milk
in PBS for 1 h and visualized using ECL (BioRad). The list
of antibodies used are listed in Supplementary Table S1.
For immunofluorescence studies, 143B cells were plated
on coverslips (at ∼70% confluency), incubated with Mi-
9388 Nucleic Acids Research, 2019, Vol. 47, No. 17
toTracker Red CMXRos for 15 min and fixed with 3%
formaldehyde. Following membrane permeabilization (1%
Triton in PBS for 5 min) and blocking (3% FBS in PBS, 1
h), cells were incubated with anti-FLAG monoclonal an-
tibodies (1:200) for 2 h, washed with PBS and incubated
with Alexa Fluor 488 conjugated anti-mouse antibodies for
1 h. Immunofluorescence images were then captured using
a Zeiss LSM800 confocal microscope.
Cell fractionation
Cell fractionation was performed as described in (16) with-
out the sucrose gradient step.
[35S]-Methionine in vivo mitochondrial translation assay
Cells on a six-well plate were washed twice for 5 min each
in methionine/cysteine-free DMEM and incubated with
methionine/cysteine-free DMEM supplemented with 10%
dialyzed FBS, GlutaMax 100X (Gibco), sodium pyruvate
100× (Gibco) and 100 g/ml emetine (Sigma-Aldrich) (an
irreversible cytosolic translation inhibitor) for 20 min at
37◦C. Cells were then incubated in the same media sup-
plemented with 166.7 Ci/ml of [35S]-methionine (Perkin
Elmer) for 30 min at 37◦C to label the newly synthesized mi-
tochondrially encoded proteins. After washing three times
with PBS, cells were lysed and 30g aliquots were separated
on 10–20% Tris-glycine (Invitrogen) SDS-PAGE gels. Gels
were dried for 2 h at 65◦C and exposed on a phosphoim-
ager screen prior to visualization with Typhoon FLA 7000
phosphoimager.
In-gel activity of mitochondrial respiratory complexes
Mitochondria isolated from the different cell types were re-
suspended in 1.5 M aminocaproic acid (ACNA), quantified
by Qubit (for loading 50 g), lysed with 4% w/v digitonin
and separated by Blue-Native Polyacrylamide Gel Elec-
trophoresis (BN-PAGE). Mitochondrial respiratory chain
enzyme activities were determined in-gel with OXPHOS
complex-specific substrate buffers as described in (17), with
minor adaptation. About 2.5 mg/ml of iodonitrotetra-
zolium chloride was used instead of nitrotetrazolium blue
in complex-I and complex-II substrate buffers.
Measurement of mitochondrial respiration
To determine mitochondrial respiration in wild-
type, C6orf203KO1 and C6orf203KO1 overexpressing
C6orf203::FLAG cell lines, high-resolution respirometry
with Oroboros Oxygraph-2K (Oroboros Instruments, Aus-
tria) was performed at 37◦C. Basal mitochondrial oxygen
consumption was measured in MIR05 medium, followed
by injection of 4.05 M of digitonin to permeabilize the
cells. After adding 2.5 M of oligomycin (Complex V
inhibitor), maximal mitochondrial oxygen consumption
was measured with 0.5 M steps of carbonyl cyanide
m-chlorophenyl hydrazone (CCCP) titration.
Immunoprecipitation of C6orf203::FLAG
Mitochondria were isolated from HEK293T Flp-In cells
overexpressing C6orf203::FLAG as described in (18) and
lysed in 1× lysis buffer (Sigma-Aldrich) supplemented
with 5 mM MgCl2 and 1× protease inhibitor cock-
tail (Roche). Anti-FLAG M2 Agarose Affinity gel beads
(Sigma-Aldrich) were used for immunoprecipitation ac-
cording to manufacturer’s instructions. The wash and elu-
tion buffers were supplemented with 5 mM MgCl2. Elu-
tion was performed with the 3× FLAG peptide (Sigma-
Aldrich). The eluate was immediately stored at −80◦C and
used for immunoblotting or processed for mass spectrome-
try.
Liquid chromatography (LC)–mass spectrometry (MS)/MS
analysis
Mass spectrometric analysis of immunoprecipitated com-
plexes was performed as described in Supplementary Data.
A list of proteins detected by MS is presented in Supple-
mentary Table S6.
RNA isolation and northern blot analysis
TRIzol (Invitrogen) reagent was used to isolate total RNA
from cells as per the manufacturer’s instructions. About 4
g of total RNA was resolved in 1.2% agarose gels with
0.7% formaldehyde and GelRed® (Biotium) in 1× MOPS
buffer. The RNA was transferred to a nylon membrane
overnight by capillary-based transfer and used for prob-
ing rRNAs and mRNAs. For tRNA northern blots, RNA
was resolved in TBE-Urea Gel (15%) in 1× TBE buffer fol-
lowed by wet transfer at 30 V for 1 h in 0.5× TBE buffer.
Membranes were then UV crosslinked and hybridized with
probes corresponding to the mitochondrially encoded mR-
NAs or tRNAs. Washing the membranes after probing was
performed with 1× SSC buffer (150 mM NaCl, 15 mM
tri-sodium citrate (pH 7.0)) supplemented with 0.1% SDS.
Probes for mRNA and tRNA were prepared by Prime-
It II Random Primer Labeling Kit (Agilent technologies)
with 50 Ci of CTP and Riboprobe® in vitro Transcrip-
tion Systems (Promega) with 50 Ci of UTP respectively,
according to manufacturer’s instructions. Oligonucleotides
and primers used for the synthesis of tRNA and mRNA
probes are listed in the Supplementary Tables S3 and S4, re-
spectively. Membranes were then exposed on a phosphoim-
ager screen and visualized using Typhoon FLA 7000 phos-
phoimager.
qRT-PCR to determine RNA interactors of C6orf203
Mitochondria isolated from HEK293T Flp-In cells and
HEK293T Flp-In cells overexpressing C6orf203::FLAG
were lysed in 1× lysis buffer (Sigma-Aldrich) supplemented
with 5 mM MgCl2 and 1× protease inhibitor cocktail
(Roche). Protein content of mitolysates were quantified
via BCA assay to load the same protein mass on Anti-
FLAG M2 Agarose Affinity gel beads (Sigma-Aldrich) for
immunoprecipitation. RNA from mitolysates (inputs) and
FLAG-immunoprecipitated eluates were extracted by TRI-
zol (Invitrogen) according to manufacturer’s instructions.
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RNAs in the inputs were quantified and used for cDNA
synthesis (reaction volume = 20 l) with high-capacity
cDNA reverse transcription kit (Applied Biosystems) and
ProFlex PCR System (Applied Biosystems). RNA purity
was assessed by the ratio of A260/A280 by NanoDrop ND-
1000 UV-Vis Spectrophotometer (Thermo Fisher Scien-
tific), to be 2.0. In addition, an equal volume of eluates
was used for reverse transcription. qPCR was performed
by QuantStudio 6 Flex Real-Time PCR System (Applied
Biosystems) with the cDNA using TaqMan Universal PCR
MasterMix (Applied Biosystems) andTaqMan probes with
FAM (6-carboxyfluorescein) reporter (Applied Biosystems)
(listed in Supplementary Table S5) with 5–10 ng of cDNA
per 10 l reaction mix. Ct values were obtained from the
in-built software (QuantStudio Real-Time PCR software
v1.1) associated with the qPCR machine and data analysis
was performed using Microsoft Office Excel. The relative
fold change of transcripts in the FLAG-primed immuno-
precipitated eluates versus the non-primed eluates were cal-
culated using the formula: ((2Ct of eluate – 2Ct of input) of
non-FLAG primed IP) / ((2Ct of eluate – 2Ct of input) of
FLAG primed IP). Figure 5C represents three biological
replicates and the error bars represents the standard error
of mean (SEM).
Analysis of mitochondrial ribosomes on sucrose gradients
Mitochondria were isolated from cells, as described in (18),
and lysed in 1× lysis buffer (Sigma-Aldrich) containing 5
mM MgCl2, 1× protease inhibitor cocktail (Roche) and
RNase block (Agilent). Approximately 500 g of protein
was loaded onto linear sucrose gradients (10–30% (v/v)),
prepared in the gradient buffer (20 mM Tris-HCl (pH 7.4),
100 mM NaCl, 20 mM MgCl2). The samples were cen-
trifuged for 15 h at 79 000 × g at 4◦C (Beckman Coulter;
SW41 rotor). 21 fractions of 450 l each were collected and
the first 17 fractions were used for western blot analysis.
Purification of C6orf203 and electrophoretic mobility shift
assay (EMSA)
A codon-optimized (Genscript) DNA construct corre-
sponding to the mature form of human C6orf203 (amino
acids 85–240) was cloned into a Fh8-Pet24d vector. Human
C6orf203 was expressed in Arctic express cells (Agilent) at
16◦C for 48 h in Magic Media (Thermo Fisher Scientific)
with an approximate yield of 5 mg/l, assessed by Bradford
protein assay. After lysis, the proteins were purified over a
His-Select Ni2+ resin (Sigma-Aldrich) and dialyzed against
H-0.2 (25mMTris-HCl (pH 7.4), 0.5mMEDTA, 10% glyc-
erol, 3 mM -mercaptoethanol and 200 mM NaCl) after
the addition of TEV protease at a 1:25 protease:protein ra-
tio. The dialyzed protein was loaded on a second Ni2+ resin
for TEV protease removal and the flow-through was col-
lected. Further purification was conducted over a HiLoad
16/60 Superdex 200 pg gel filtration column (GE Health-
care) in buffer H-0.2 lacking glycerol with the addition of 2
mM dithiothreitol instead of -mercaptoethanol. The pu-
rity was estimated at ∼95% following SDS-PAGE gel elec-
trophoresis and staining with Coomassie (Supplementary
Figure S1A). RNA EMSA were performed as previously
described (19).
Mitoribosome profiling
The ribosome profiling experiment was performed as de-
scribed previously (20), with minor modification. During
separation of ribosome protected fragments (RFPs) on
15% denaturing polyacrylamide gel, a wider range of RNA
species (migrating between 10 and 50 nt) was excised from
the gel. Computational analysis is described in Supplemen-
tary Data.
Statistics
The data represented from oxygraph and growth curve are
derived from themean values. Error bars represent the stan-
dard deviation. Statistical analyses were performed as two-
tailed, unpaired-unequal variance Student’s t-tests. The sig-
nificance threshold was set at P < 0.05; indicated as * for P
< 0.05, ** for P < 0.01 and *** for P < 0.001.
RESULTS
C6orf203 has a predicted S4-like RNA-binding domain
BLAST analysis revealed an S4-like RNA-binding domain
within the human C6orf203 protein (Figure 1A). This do-
main received its name through its initial identification in
the prokaryotic integral ribosomal protein S4 (RPS4) (14).
RPS4 binds to 16S rRNA in the maturing 30S subunit of
the bacterial ribosome, and promotes correct rRNA fold-
ing during ribosomal subunit assembly (21), as well as bind-
ing to its own mRNA to repress translation (22). The RPS4
protein consists of two RNA-binding domains (Figure 1A),
both ofwhich form extensive contacts with rRNA in the 30S
subunit (23). However, it is the C-terminal domain of RPS4,
termed the S4-like RNA binding domain, which demon-
strates conservation to the C-terminal domain of C6orf203
(Figure 1A). Comparison of the predicted folding of the
S4-like RNA-binding domain of C6orf203 to the previ-
ously resolved S4-like RNA-binding domain of Escherichia
coliRPS4 (PDB:3J9Y) suggests structural conservation be-
tween the two domains (Figure 1B and C), characterized
by an -helical bundle packed against anti-parallel -sheets
(23).
The S4-like RNA-binding domain consists of 60–65
amino acids, with key conserved residues coordinating
RNA binding (Figure 1D). The S4-like domain has been
found in a diverse range of RNA-interacting proteins across
different species. The exact location of the S4-like domain
can vary within protein sequence and is often found in
combination with additional functional protein domains,
including those which confer enzymatic activity (Figure
1A). Alignment of primary sequences of proteins across
phylogeny was performed to demonstrate the diversity of
S4-like domain containing proteins: H. sapiens ribosomal
protein S9, E. coli tyrosyl-tRNA synthetase, Marchantia
paleacea chloroplast ribosomal protein S4, C. sporogenes
rRNA methyltransferase, S. cerevisiae bifunctional protein
RIB2 pseudouridylate synthase (Figure 1A and D). The
S4-like domain provides RNA-binding ability to these pro-
teins, positioning the functional domains to their cognate
RNAs (14). Whilst the biological role of these extra do-
mains has been characterized in many of these proteins
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Figure 1. C6orf203 contains an S4-like RNA-binding domain (A). Domain architecture of a diverse selection of proteins containing S4-like RNA-binding
domains, including Homo sapiens C6orf203 (Q9P0P8), Escherichia coli 30S ribosomal protein S4 (RPS4) (P0A7V8), Clostridium sporogenes NJ4 rRNA
methyltransferase (A0A2P8MJ46), E. coli tyrosyl-tRNA synthetase (P0AGJ9) and Saccharomyces cerevisiae bifunctional protein RIB2 pseudouridine
synthetase (Q12362). Proteins are aligned with respect to their S4-like domain (blue) with additional characterized functional domains indicated for
each protein. Additional functional domains: NS4/S9 – N-terminal S4/S9 RNA binding domain; FtsJ, FtsJ-like methyltransferase; tRNA synth, tRNA
synthetase class I domain (W and Y), PseudoU synt, RNA pseudouridylate synthetase. (B) Previously resolved structure of E. coli ribosomal protein S4
(PDB: 3J9Y). The C-terminal S4-like RNA-binding domain is enlarged and highlighted in yellow. (C) Structural prediction of the S4-like RNA-binding
domain of humanC6orf203. Predictionwas generated in SWISS-MODEL (38) using the primary sequence residues 143–216 of humanC6orf203 (Q9P0P8),
and modeled in USCF Chimera (39). (D) Multiple protein sequence alignment of the S4-like RNA-binding domain of several family member proteins,
includingH. sapiensC6orf203. Alignment of protein sequence was constructed usingClustal Omega (40). The conserved positions are shaded using the 80%
consensus rule. The amino acid classes used in building the consensus were as follows: red, polar residues; green, hydrophobic residues; gray boxes, small
residues. Names of the proteins are as assigned in UniProt: RPS4 E. coli: ribosomal protein S4, Escherichia coli (P0A7V8); RS4 (chloroplast) M. palacea:
chloroplast ribosomal protein S4,Marchantia paleacea (P06358); RPS9 H. sapiens: 40S ribosomal protein S9,Homo sapiens (P46781); rRNAmethylase C.
sporogenes: rRNAmethyltransferase,Clostridium sporogenes (A0A2P8MJ46); TyrS E. coli: Tyrosyl-tRNA synthetase, Escherichia coli (P0AGJ9); RIB2 S.
cerevisiae: RIB2, Saccharomyces cerevisiae (Q12362). (E) RNA electrophoretic mobility shift assay (EMSA) indicating preference of C6orf203 for binding
double stranded RNA. Recombinant human C6orf203 was incubated with fluorescein-labeled RNAs (100 nM). RNA template sequences used were as
indicated (nt. position in mtDNA). Protein concentrations used were 0, 0.02, 0.04, 0.08, 0.16, 0.36, 0.64, 1.28, 2.56 M, respectively. (F) Quantification of
proportion of unbound RNA ligand relative to no addition of C6orf203 protein, as in Figure 1E. Dissociation constant (Kd) of RNA ligand with C6orf203
is indicated for experiments where it could be determined.
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(Figure 1A), our attempts to predict previously character-
ized functional domains in C6orf203, aside from the S4-like
domain, through either BLAST search or iTASSER pre-
diction (Iterative Threading ASSEmbly Refinement (24) ),
were unsuccessful.
With evidence suggesting that C6orf203 contains a func-
tional S4-like RNA binding domain, we sought to deter-
mine if recombinant human C6orf203 possesses the ability
to bind RNA in vitro by performing electrophoretic mo-
bility shift assays (EMSA). EMSA did not indicate affin-
ity of C6orf203 to a fluorescein-labeled single stranded
(ss)RNA template (a portion of ATP6 mRNA, mtDNA
nt. 8657–8685) (Figure 1E and F). In contrast, when in-
cubated with double-stranded (ds)RNA templates, either
portions of 16S mt-rRNA (mtDNA nt. 1919–1985) or mt-
tRNAPro (mtDNA 15956–16023), C6orf203 demonstrated
binding affinity (Figure 1E and F), with Kd values of
0.23 and 0.29M, respectively. In addition, we repeated
our C6orf203 EMSA with fluorescein-labeled mt-tRNAPro
dsRNA in the presence of either unlabeled ssRNA or struc-
tured dsRNA molecules at a concentration 100-fold higher
than the labeled mt-tRNAPro (Supplementary Figure S1B).
Whilst the unlabeled mt-tRNAPro dsRNA was success-
ful in competing with the labeled RNA, preventing bind-
ing of C6orf203, no such competition was observed for
the unlabeled ssRNA template, supporting the notion that
C6orf203 preferentially binds structured RNA over linear
templates. Together, these data suggest that C6orf203 pos-
sesses RNA-binding ability, with specificity for binding ds
and/or highly structured RNA.
C6orf203 localizes to the mitochondrial matrix
We next sought to characterize the subcellular localiza-
tion of C6orf203. According to the MitoCarta 2.0 in-
ventory, C6orf203 is predicted to localize to mitochon-
dria in humans (13). In order to confirm the predic-
tion, we performed immunocytochemistry (ICC) of human
143B osteosarcoma (HOS) cells transiently transfected with
cDNA of C6orf203 tagged with a C-terminal FLAG epi-
tope tag (C6orf203::FLAG). Resultant ICC images indi-
cated strong colocalization of C6orf203::FLAG with Mi-
toTracker Red CMXRos (Figure 2A), indicating a pre-
dominantly mitochondrial localization of the recombinant
C6orf203::FLAG protein.
We next generated a HEK293T cell line, which allowed
for inducible overexpression of C6orf203::FLAG via the
Flp-In TREx system (Invitrogen). Subcellular fractionation
of HEK293T cells overexpressing C6orf203::FLAG further
supported our ICC findings that C6orf203 localizes to hu-
man mitochondria (Figure 2B). Although FLAG signal
for the C6orf203::FLAG was too weak to detect in total
lysate (T), C6orf203::FLAG was evident in the mitochon-
drial fraction, indicating an enriched localization of the pro-
tein to mitochondria (Figure 2B). Following Proteinase K
treatment of isolated mitochondria, C6orf203::FLAG re-
mains intact, similar to the behavior of mitoribosome sub-
unit proteins uL3m and uS15m, while cytosolic ribosomal
protein uL1 and outer mitochondrial membrane protein
TOM20 are both degraded by Proteinase K treatment (Fig-
ure 2B). This indicates that the C6orf203::FLAGprotein re-
mains protected from proteolysis within mitochondria. To-
gether, these results confirm that C6orf203 localizes to mi-
tochondria in human cultured cells.
Mitochondrial gene expression is perturbed in the absence of
C6orf203
As the EMSA results have suggested that C6orf203 may
have RNA-binding capability (Figure 1E), we sought to ex-
plore the role of C6orf203 in mitochondrial gene expres-
sion. To investigate this, several knockout HEK293T cell
lines (KOs) were produced using CRISPR/Cas9 technology
(15) and knockout was confirmed via western blotting (Fig-
ure 3A) and PCR analysis (Supplementary Figure S2B).
KO1 and KO4 were chosen for future analysis.
To assess mitochondrial function in the C6orf203 knock-
out lines, clones were cultured in media containing galac-
tose as the sole carbon source, which forces cells to rely al-
most entirely on mitochondria for ATP production. A re-
duced ability of KO clones to proliferate in galactose me-
dia relative to the growth of wild-type (WT) HEK293T cell
line population was observed (Figure 3B), suggesting a mi-
tochondrial dysfunction.
To further investigate this observation, western blotting
of OXPHOS subunits was performed, indicating a mild re-
duction in the steady-state levels of components of complex
I (NDUFB8) and IV (COX1 and COX2) (Figure 3C), sug-
gesting that the C6orf203 knockout interferes with mito-
chondrial gene expression.
In order to confirm that the observed OXPHOS defi-
ciency was due to the loss of the C6orf203 protein, we com-
plemented the KO1 clone via the Flp-In T-Rex system to al-
low for inducible expression of wild-type C6orf203::FLAG
cDNA (Figure 3D).We nextmeasured oxygen consumption
rates in knockout and complemented cell lines. The ratio of
maximal respiration to basal respiration was modestly de-
creased in the absence of C6orf203 (Figure 3E), which was
in line with the moderate decrease in the steady-state levels
of components of OXPHOS complexes. This mild decrease
was rescued by re-expression of C6orf203::FLAG protein,
also confirming that FLAG-tagged protein can functionally
substitute endogenous C6orf203.
In addition, in-gel activity of OXPHOS complexes were
analyzed for both knockout and complemented lines (Fig-
ure 3F). Activity of complexes I, II and IV was unchanged
or mildly affected for tested KO clones (Figure 3F). How-
ever, upon staining for in-gel activity of complex V, we ob-
served activity derived from complexes of a reduced molec-
ular mass relative to the F1F0 holoenzyme (Figure 3F). Due
to the presence of ATP hydrolysis, these are likely formed
due to F1-containing subcomplexes. This suggests that a
mild assembly defect is occurring in complex V in the ab-
sence of C6orf203, which is rescued upon the re-expression
of C6orf203::FLAG cDNA (Figure 3F). Together, these re-
sults support that C6orf203 contributes to efficient OX-
PHOS integrity within mitochondria, due to the mild phe-
notype present upon C6orf203 ablation.
In light of the localization of C6orf203 to mitochon-
dria, we sought to determine if the mild OXPHOS phe-
notype in C6orf203 KO was directly attributable to a de-
fect inmtDNA expression.Metabolic labeling ofmitochon-
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Figure 2. C6orf203 localizes to the mitochondrial matrix in human cells. (A) Intracellular localization of C6orf203 via immunocytochemistry.
C6orf203::FLAG cDNA was transiently transfected into HOS cells. Cell nuclei were stained with DAPI (blue). The C6orf203::FLAG protein product
was detected via an anti-FLAG antibody and visualized using a secondary antibody conjugated to Alexa Fluor 488 (green). Mitochondria were visu-
alized using MitoTracker Red CMXRos (red). A digitally merged image of DAPI, Alexa Fluor 488 and MitoTracker signals reveals colocalization of
C6orf203::FLAG with the mitochondrial network; scale bar = 10 m. (B) Subcellular fractionation of HEK293T cells expressing C6orf203::FLAG pro-
tein. HEK293T cell lysates were fractionated into cytosolic and mitochondrial fractions. In addition, aliquots of the mitochondrial fractions were treated
with 25 g/ml Proteinase K with or without treatment with 1% Triton X-100. Fractions (40 g) were analyzed by western blotting and the localization of
C6orf203::FLAG was assessed in comparison to that of protein markers of the cytosol (cytosolic ribosomal protein uL1), outer mitochondrial membrane
(TOM20), and mitochondrial matrix (mitochondrial ribosomal protein uL3m and uS15m). T, total cell lysate; D, debris; C, cytosolic fraction.
drial translation products indicated a strong, general trans-
lation defect in independent KO clones (about 50% com-
pared to control, n = 3), which was restored upon expres-
sion ofC6orf203::FLAG cDNA inKO1 (Figure 4A). As our
earlier findings (Figures 1E and 2) suggest that C6orf203
may function as a mitochondrial RNA-binding protein, we
next investigated whether alteration to the mitochondrial
transcriptome was an underlying factor to the mitochon-
drial translation defect observed in C6orf203 KO. However,
northern blotting of all mtDNA-encoded mRNAs, rRNAs
and tRNAs (Figure 4B, C and D) did not indicate any
change to steady-state levels, nor disturbance in RNA pro-
cessing, that would explain the severe, general mitochon-
drial translation defect observed.
C6orf203 interacts with the mitochondrial ribosomal large
subunit
As no steady-state level change of any of the mitochondrial
transcripts was observed, we next sought to identify specific
interactions of C6orf203, as this may provide more insight
into the underlying mechanism of the observed mitochon-
drial translation defect. Following C6orf203::FLAG induc-
tion in our overexpressing HEK293T line, FLAG immuno-
precipitation (IP) without crosslinking was performed. To
control for non-specific binding, FLAG-tagged mitochon-
drially targeted luciferase was expressed in HEK293T and
immunoprecipitated by the same procedure (Supplemen-
tary Figure S3B). Western blotting of the eluate revealed
specific enrichment of proteins of the mt-LSU (mL37 and
uL3m) in C6orf203 pulldown, while protein subunits of the
mt-SSU were not enriched (Figure 5A). Additionally, we
found that the observed interaction with mt-LSU subunits
was RNA-dependent, since RNase A treatment led to a loss
of interaction of C6orf203 with mL37 and uL3m (Supple-
mentary Figure S3C).
Next, we performed label-free quantitative mass spec-
trometry on the eluate from the C6orf203::FLAG IP rel-
ative to a negative control (HEK293T without FLAG pro-
tein expression). This revealed enrichment of a large num-
ber of proteins of the mt-LSU that co-immunoprecipitated
with C6orf203::FLAG (Figure 5B), while only a single sub-
unit of the mt-SSU was observed (uS15m) with a logFC of
>2. Indeed, when the enrichment profiles of the constituent
proteins from the mt-LSU and the mt-SSUwere considered
separately, all mt-LSU subunits showed a consistent enrich-
ment over global protein distribution, while mt-SSU pro-
teins were not enriched over that of global proteins (Figure
5B, inset). We also observed enrichment of several cytosolic
ribosomal proteins. However, this interaction was reduced
upon Proteinase K treatment of mitochondria prior to IP,
as tested via western blotting (Supplementary Figure S3A).
In addition to mt-LSU components, a number of other
proteins were highly enriched in C6orf203::FLAG IP, in-
cluding a number of factors known to be involved in as-
sembly of the mt-LSU (i.e. GTPBP10, DHX30, MALSU1,
RPUSD4, TRMT10C) (Figure 5B). As many of these as-
sembly factors would likely be excluded from the mature
ribosome, this may indicate that the observed interaction
of C6orf203 occurs within an assembly intermediate of the
mt-LSU.
Curiously, one of the most highly enriched proteins ob-
served upon C6orf203::FLAG pulldown was C12orf65, a
member of a family of four mitochondrial class I peptide
release factors. However, the exact role of C12orf65 in mi-
tochondrial translation is currently unknown, with family
member mtRF1a having been found to be sufficient for ter-
mination of translation in all 13 mitochondrial open read-
ing frames (25). The interaction of C12orf65 with C6orf203
requires further investigation to determine functional rele-
vance.
As we have earlier characterized C6orf203 as having
RNA-binding affinity, we sought to investigate whether
C6orf203 interacted with mitochondrial RNAs and so re-
peated our C6orf203::FLAG immunoprecipitations and
extracted RNA from both input and eluates for the
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Figure 3. Mitochondrial gene expression is perturbed in the absence of C6orf203. (A)Western blotting to confirm knockout of C6orf203 in HEK293T lines
KO1, KO2, KO4 andKO6. Total lysate fromWT andKO clones was resolved via SDS-PAGE, immunoblotting was performed andmembranes were probed
with anti-C6orf203 antibody and anti-GAPDH as a loading control. (B) Growth curve of WT HEK293T, and C6orf203 KO cells in DMEM containing
0.9 g/l galactose (three biological replicates were performed andmean average cell numbers at each time point is indicated, error bars= 1 SD). (C) Western
blotting of OXPHOS subunits in C6orf203 KO lines. Total lysate fromWTHEK293T and C6orf203 KO1 and KO4 was resolved via SDS-PAGE; Western
blotting was performed and membranes were probed with antibodies against C6orf203 and both mtDNA-encoded (COX1, COX2) and nuclear-encoded
(NDUFB8, SDHA, ATP5a) OXPHOS subunits. Anti-VDAC1 antibody was used as loading control. (D) Western blotting was performed on the control
HEK293T (WT), C6orf203 KO1 cells and KO1 cells expressing C6orf203::FLAG (KO1+C6::F) that were used for Oxygraph in (E). Antibody staining
against C6orf203 was performed to confirm knockout of C6orf203, and re-expression of the C6orf203::FLAG protein. -tubulin was used as loading
control. (E) Ratio of maximal and basal mitochondrial respiration (each expressed in pmol of oxygen flux/mg of protein) measured by Oroboros oxygraph.
Maximal respiration was measured after permeabilization of the cells (with Digitonin), inhibition of complex V (with Oligomycin) and treatment with the
protonophore (CCCP) (n = 3, * P-value = 0.0308). (F) BN-PAGE and in-gel activities of complex I, complex II, complex IV and complex V activities in
mitochondrial protein extracts from WT, C6orf203 KO clones and KO1 cells expressing C6orf203::FLAG (KO1+ C6::F). Coomassie staining of the gel is
shown to indicate equal loading. Asterisk indicates accumulated F1-containing sub-complexes of complex V.
C6orf203::FLAG line and WT HEK293 control. Through
quantitative RT-PCR focused on mt-mRNAs and mt-
rRNAs, we observed specific enrichment of 16S mt-rRNA
upon C6orf203::FLAG IP compared to control (Figure
5C). This observation further supports our proteomic find-
ings concerning interaction of C6orf203 with either the full
or a near-assembled intermediate of mt-LSU.
Absence of C6orf203 leads to reduction of mt-mRNAs loaded
onto mitoribosomes
In light of the observed interaction between C6orf203 and
the mt-LSU, as well as the enrichment of a complement
of known mt-LSU assembly factors (Figure 5B), we next
sought to assess the integrity of the mitoribosomes in our
C6orf203 KO lines. Western blotting revealed no decrease
of steady-state levels of a number of constituent proteins of
either the mt-LSU ormt-SSU (Figure 6A), and sucrose gra-
dient fractionation indicated that overall integrity of both
the mt-SSU and mt-LSU was retained in the C6orf203 KO
clones (Figure 6B). This suggests that there is no global de-
fect in the assembly of either subunit of themitoribosome in
the absence of C6orf203 (Figure 6B), and soC6orf203 is un-
likely to play a role in the early stages of assembly of the mt-
LSU. This is consistent with the observation of a near-full
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Figure 4. Knockout of C6orf203 leads to decreased mitochondrial translation without affecting the steady-state levels of mitochondrial RNAs. (A) Mi-
tochondrial translation in C6orf203 KO cell lines. Following inhibition of cytosolic translation, products of mitochondrial translation were labeled with
[35S]-methionine in WT, C6orf203 KO clones and KO1 cells expressing C6orf203::FLAG (KO1+C6::F, numbers indicate clones 1 and 2). Mitochondrial
proteins were separated by SDS-PAGE and visualized by autoradiography. Coomassie Brilliant Blue (CBB) staining is provided to confirm equal pro-
tein loading. Immunoblotting was used to show C6orf203 expression. (B) Northern blotting of mt-mRNAs (B), mt-rRNAs (C) and mt-tRNAs (D) for
WT and C6orf203 KO clones. Nuclear-encoded 28S and 18S rRNA were used as a loading control for mt-mRNAs and mt-rRNAs, and cytosolic tRNA
(Tryptophan) was used as a loading control for mt-tRNA blots.
complement of mt-LSU proteins upon C6orf203::FLAG
pulldown (Figure 5B), suggesting instead that C6orf203
may act on a later stage assembly intermediate of mt-LSU
or the full mt-LSU.
Curiously, despite the observed translational defect in
C6orf203 KO cells (Figure 4A), mitochondrial monosome
formation is not affected in the absence of C6orf203 (Fig-
ure 6B). To investigate this disparity between mitochon-
drial monosome formation and the strong translation de-
fect present inC6orf203KO,we employedmitochondrial ri-
bosome profiling (MitoRiboSeq) in one of theC6orf203KO
lines (KO1). Through this, we observed that occupancy of
all mt-mRNAs on mitochondrial monosomes was greatly
reduced relative toWTHEK293T (Figure 6C), although no
specific mt-mRNAs were affected to a greater extent than
others (Figure 6C). The MitoRiboSeq results are in accor-
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Figure 5. C6orf203 interacts with the mt-LSU. (A) Immunoblotting of C6orf203::FLAG pulldown. Input mitochondrial lysates and eluate of FLAG-IP
from HEK293T expressing C6orf203::FLAG and control HEK293T without FLAG protein expression (WT) were resolved via SDS-PAGE; western blot-
tingwas performed and subsequentmembraneswere probedwith antibodies against FLAGand for proteins of either themt-LSUproteins (mL37, uL3m) or
mt-SSU proteins (bS16m, uS15m). (B) Mass spectrometry analysis of proteins interacting with C6orf203::FLAG. Following FLAG-immunoprecipitation,
eluates were analyzed by label-free quantitative mass spectrometry (LFQ) (n= 3). Volcano plot indicates only proteins found in theMitocarta 2.0 database.
Proteins with fold change >2.5 are marked. Inset: Boxplot displaying comparison of the logFC (log fold change) of proteins (as in main B) of the mt-LSU
or mt-SSU in comparison to global proteins. Stated P-values indicate pair-wise significance of difference in logFC between global proteins, 39S mt-LSU
proteins or 28 mt-SSU proteins as determined viaWelch’s unequal variances t-test. (C) Quantitative real-time PCR to assess enrichment of mt-RNAs upon
C6orf203::FLAG pulldown. Anti-FLAG Immunoprecipitation was performed on mitochondrial lysate from HEK293 cells and HEK293T cells overex-
pressing C6orf203::FLAG. RNAwas extracted from both mitochondrial lysates and elution fractions, reverse transcribed, and qPCRwas performed using
primer and probes pairs to mitochondrial DNA encoded transcripts. The relative fold change of transcript abundance in the C6orf203::FLAG immuno-
precipitated eluates versus the HEK293 eluates relative to transcript abundance in their respective input mitochondrial lysates were calculated and are
shown here. Graph represents combination of three biological replicate experiments; error bars = S.E.M.
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Figure 6. C6orf203 loss affects the engagement of mt-mRNAs with mitoribosomes. (A) Western blotting of steady-state levels of mitochondrial ribosomal
proteins in WT, C6orf203 KO and KO1 cells expressing C6orf203::FLAG (KO1+C6::F). Total cell lysate from WT HEK293T, C6orf203 KO clones and
KO1 cells expressing C6orf203::FLAG (KO1+C6F) was resolved via SDS-PAGE; Western blotting was performed and membranes were probed with
antibodies against proteins of either the mt-LSU or mt-SSU, and VDAC1 was used as loading control. (B) Sedimentation of mitochondrial ribosomes on
10–30% isokinetic sucrose gradients for WTHEK293T and C6orf203 KO1. Mitochondria were isolated from cells, and lysates were loaded onto gradients.
Following centrifugation, obtained fractions were analyzed by western blotting with antibodies against proteins of the mt-LSU (uL3m and mL37), the
mt-SSU (uS15m) and C6orf203. (C) Mitoribosome profiling analysis. Relative ratio of mitoribosome-protected fragments (per million mapped reads,
RPM) for C6orf203 KO1 versus WT HEK293T for each mt-mRNA ORF determined via MitoRiboSeq. Individuals CDSs are displayed according to
their ORF length. Reads with 5′ ends mapping between the first nucleotide of the start codon and 30 nt 5′ of the stop codon were counted for each library.
Overlapping regions for ORFs on bicistronic transcripts (ATP8/ATP6 and ND4l/ND4) were excluded from the analysis. Results represents data from a
single MitoRiboSeq experiment.
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dance with themitochondrial translation defect observed in
C6orf203 KO (Figure 4A).
Further analysis ofMitoRiboSeq revealed that, although
the engagement of mRNAs with mitoribosomes is de-
creased, once the mRNAs are loaded and translation ini-
tiated, there is no major disturbance in the elongation effi-
ciency, as no obvious difference in mitoribosome pausing
was observed between KO and WT cells (Supplementary
Figure S4A and B), nor mitoribosome drop-off across the
length of translated transcripts (which could indicate spu-
rious loss of reading frame) (Supplementary Figure S4C).
Additionally, we did not observe any increase in occupancy
of the mitoribosomes on specific codons in the C6orf203
knockout lines, which suggests that there is no perturba-
tion of the availability of any individual aminoacylated
mt-tRNA (Supplementary Figure S5). Taken together, in
the absence of C6orf203, mitochondrial monosomes are
formed, but their function is compromised, resulting in re-
duced mitochondrial translation.
DISCUSSION
Many aspects of mitochondrial gene expression remain elu-
sive, including assembly of the mitoribosome and regula-
tion of mitochondrial translation. These processes require
the assistance of multiple trans-acting factors, and in recent
years, the identity of a number of proteins involved have
been discovered (26). Here, we present the initial charac-
terization of the role of the putative RNA-binding protein
C6orf203 in mitochondrial gene expression, suggesting that
C6orf203 can be added to the growing group of factors that
interact with themitoribosome and are required for efficient
mitochondrial translation.
In our study, knockout of C6orf203 in HEK293T did
not lead to a strong OXPHOS deficiency, despite the mi-
tochondrial translation defect observed. This milder phe-
notype may explain why C6orf203 has not previously been
identified as an essential gene for OXPHOS (27).
In the C6orf203 knockout cell lines, we saw defects in
in-gel activity only for complex V, in the form of sub-
assemblies, which retained ATP hydrolysis, whilst the ac-
tivity of other OXPHOS complexes was largely unaffected
(Figure 3F). It has previously been noted that such sub-
assemblies of complex V are rather a sensitive marker of
overall mitochondrial gene expression, as opposed to a spe-
cific defect in mtDNA-encoded complex V subunit expres-
sion (28). Indeed, our MitoRiboSeq data do not suggest
that the translation of ATP6 and ATP8 is disproportion-
ately affected when compared to that of other mt-mRNA
ORFs (Figure 6C). Therefore, we conclude that our ob-
served defect to complex V is likely to be due to the nature
of sensitivity of ATP synthase assembly to a reduction in
mitochondrial gene expression, and not a specific effect of
the loss of C6orf203 function.
C6orf203 is a conserved mitochondrial RNA-binding protein
that interacts with the mt-LSU
An NCBI SMARTBLAST (https://blast.ncbi.nlm.nih.
gov/smartblast/) using the primary sequence of human
C6orf203 revealed homologues with high levels of iden-
tity not only in vertebrates, but across the whole animal
kingdom (Supplementary Figure S6). As with human
C6orf203, each of these proteins are predicted to possess
a conserved S4-like RNA-binding domain, suggesting
functional conservation.
Many of the proteins identified thus far to contain the
S4-like RNA-binding domain interact with highly struc-
tured RNA, such as the prokaryotic ribosomal protein S4
that interacts with 16S rRNA (29) or tyrosyl-tRNA syn-
thetase that binds to tRNATyr (14). Indeed, our EMSA
assays indicated a preference of human C6orf203 to bind
structured RNA in vitro, displaying higher affinity to a por-
tion of 16S mt-rRNA and a portion of mt-tRNAPro, both
predicted to formdsRNA, as compared to a single-stranded
section of ATP8/6 mt-mRNA. This preference for bind-
ing dsRNA was previously observed upon application of
EMSA for other mitochondrial proteins known to bind
the mitoribosome, mTERF3 and the NSUN4/MTERF4
complex (30,31). Of particular note, theNSUN4/MTERF4
complex displayed no affinity for ssRNA but was able to
bind predicted dsRNAportions of 16Smt-rRNA (31), simi-
lar to the behavior we have observed here for C6orf203 (Fig-
ure 1E).
With EMSA suggesting that C6orf203 has the capacity
to bind RNA in vitro, determining the exact target RNAs
of C6orf203 in the mitochondrial transcriptome would be
advantageous to discern the exact function of C6orf203.
Whilst it cannot be excluded that C6orf203 has multiple
binding sites in the mitochondrial transcriptome, the en-
richment of core mt-LSU proteins upon C6orf203::FLAG-
IP may indicate C6orf203 binding to RNA integral to the
mt-LSU i.e. 16S mt-rRNA, or possibly mt-tRNAVal incor-
porated into mt-LSU (32), supported by our observed en-
richment of 16S mt-rRNA in IP eluates, determined via
qRT-PCR (Figure CC).
In support of our observation of direct interaction of
C6orf203 with the mtLSU, C6orf203 was observed in the
previously published study where interacting partners of in-
tegral mitochondrial ribosomal protein ICT1 (mL62) were
identified (18). As ICT1 is an integral protein of mt-LSU,
it is likely that the observed interaction of ICT1 with
C6orf203 in this study is mediated through an mt-LSU
complex.
Indeed, the interaction of C6orf203 with mt-LSU sub-
units was found to be RNA dependent, as RNase treat-
ment led to loss of interaction with mt-LSU proteins (Sup-
plementary Figure S3C). Whilst this does not necessarily
indicate that C6orf203 binds directly to RNA to facilitate
binding to mt-LSU, it does indicate that the association of
C6orf203 to at least some mt-LSU proteins observed in the
FLAG-IP (Figure 5) are likely mediated through an intact
mt-LSU subunit or assembly intermediate.
The mitochondrial translation defect in the absence of
C6orf203, assessed via both [35S]-Met labeling andMitoRi-
boSeq profiling, is global in nature with translation of all
mtDNA-encoded open reading frames affected to a simi-
lar extent. If the primary mechanism of C6orf203 knockout
was mediated through the lack of C6orf203 action on a spe-
cific mt-tRNA or mt-mRNA species, it is anticipated that a
more specific effect on translation would be observed, either
by reduced translation of affected mRNAs or reduced use
of tRNAs. As we did not observe these specific changes, a
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loss of interaction of C6orf203 with mt-LSU, therefore, has
the greatest potential to be the underlying primary defect in
the global mitochondrial translation phenotype observed.
Interestingly, despite specific enrichment of core mt-LSU
proteins observed in our FLAG::IP experiments, we did not
observe co-sedimentation of the C6orf203 protein with ei-
ther themt-LSU ormonosome in our sucrose gradient frac-
tionation experiments (Figure 6B). However, this observa-
tion does not exclude that C6orf203 may bind to mt-LSU
or a late stage assembly intermediate, as previously the in-
teractions of the factors that transiently associate with the
mitochondrial ribosome (e.g. mtRRF and GTPBP10) were
also not seen in standard sucrose gradient fractionations,
but were detected in immunoprecipitation experiments (33,
34-for HEK293T cells). This could instead indicate that the
interaction of C6orf203 with mt-LSU is either transient in
nature, or difficult to capture in the experimental conditions
employed in our sucrose gradient fractionation.
Role of C6orf203 in mitoribosome function
Through bioinformatic analysis, we failed to attribute any
previously characterized enzymatic functionality to the N-
terminal portion of C6orf203. It is possible instead that
portions of the C6orf203 protein beyond the S4-like do-
main are required for co-ordinating RNA binding, or for
enabling further protein–protein interactions. For exam-
ple, the resolved structure of the bacterial ribosome (PDB:
4V7U) indicates that E. coli ribosomal protein S4 facil-
itates RNA binding via amino acid residues throughout
the protein sequence, not just limited to the S4-like do-
main (23,29). Through this extensive RNA binding, RPS4
acts at multiple stages in bacterial ribosome assembly to
aid the folding of a highly structured conformation of 16S
rRNA (21). More in-depth analysis into the exact residues
of C6orf203 required for RNA binding, through either
amino-acid substitution, or by obtaining high-resolution
structures of C6orf203 bound to mt-LSU, would reveal the
contribution of specific C6orf203 residues for mt–RNA in-
teraction.
Alternatively, it is possible that the N-terminal portion
of C6orf203 is required for recruiting further protein fac-
tors to the mt-LSU. In this manner, C6orf203 binding may
aid directly in recruitment of mt-LSU proteins or other as-
sembly factors to maturing late stage assembly intermedi-
ates, or through primingRNAstructure for protein binding.
This function may be especially important in light of the in-
creased protein complement in the human mitochondrial
ribosome as compared to the prokaryotic ribosome (10).
Despite the observed defect in mitochondrial translation
upon C6orf203 knockout, sucrose gradient fractionation
indicated that 55S monosomes are still formed. However,
MitoRiboSeq revealed a reduced amount of mRNA asso-
ciating with these monosomes, suggesting a problem with
mRNA loading or its increased dissociation from the 55S
prior to translation elongation.
Previously, a knockout mouse model of SLIRP, a protein
which binds to and stabilizes mRNA-binding protein LRP-
PRC, led to a loss of engagement of mt-mRNAs with the
mitochondrial monosome in liver (35). In this case, despite
the observation that mitochondrial monosome assembly is
unaffected, the engagement of mRNAs with the mitori-
bosomes is impaired, leading to decreased mitochondrial
translation. Together, the SLIRP study along with our find-
ings herein support the idea that the mitochondrial mono-
some can exist without mRNA being required to be loaded
onto it. In bacteria, initiation of translation by 70S mono-
some is a frequent mode of translation of non-canonical
transcripts (leaderless and polycistronic mRNAs) (36,37).
Considering the fact that mitochondrial mRNAs are lead-
erless, it is tempting to speculate that also in mitochondria,
loading of mRNA is initiated by the monosome, not the
mt-SSU, and C6orf203 action on mt-LSU is necessary to
generate functionally competent 55S ready for translation
initiation.
In conclusion, we identify C6orf203 as a novel RNA-
binding protein that interacts with the mt-LSU and is re-
quired for efficient translation in human mitochondria.
Further structural studies would be invaluable in discern-
ing both the interaction site of C6orf203, and whether an
as-yet-uncharacterized late stage assembly intermediate of
mt-LSU is present in the absence of C6orf203.
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